Identification of Serum Metabolite Biomarkers and Metabolic Reprogramming Mechanisms to Predict Recurrence in Cholangiocarcinoma
Ontology highlight
ABSTRACT: Cholangiocarcinoma (CCA) has high recurrence rates that severely limit long-term survival. Effective tools for accurate recurrence monitoring and diagnosis remain lacking. Metabolic reprogramming, a key driver of CCA growth and recurrence, is underutilized in cancer screening and management. This study aimed to identify metabolite-based biomarkers to evaluate recurrence severity, enhance disease management, and elucidate the molecular mechanisms underlying CCA recurrence.
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: Watcharin Loilome
PROVIDER: PXD060214 | JPOST Repository | Wed Mar 19 00:00:00 GMT 2025
REPOSITORIES: jPOST
ACCESS DATA